Inflammatory Bowel Disease Clinical Trial
Official title:
Evaluation of the Video Capsule Colonoscopy for the Detection and the Control of Colon Lesions in Children Presenting Confirmed or Suspected Inflammatory Bowel Disease
The incidence of Inflammatory Bowel Diseases (IBD) is in a continuous progression both in
adults as in children. The colonoscopy is considered as the gold standard exam for the
diagnosis and the follow-up of the patients presenting or suspected to have an IBD. The
follow-up and financial management of this kind of pathology is very much dependent on the
quality of the endoscopic images. Because colonoscopy is an expensive and invasive technique
which assumes a general sedation, many efforts have been done to develop new less expensive
and less invasive techniques in order to offer alternatives to the classic colon endoscopy.
One of these new techniques is the colon videocapsule (CVC) endoscopy (PillCam® colon 2 -
Given Imaging, Yoqneam, Israel). This is a new promising semi-invasive endoscopic technique
which has been successfully validated with adults. We hypothesize that the CVC can be used in
children with similar results in terms of efficacy, as is the case for adults.
This prospective simple blind multicenter study, will investigate the diagnostic value of the
CVC compared to the conventional colonoscopy under general sedation for the detection and the
control of colon lesions in children presenting IBD.
If the feasibility and the efficacy of the colon video capsule technique are also proven for
use with children, then this new technique might become a very interesting alternative for
the endoscopic examination of the colon because of being less expensive and less invasive.
Moreover, this technique would be very useful as a means of lesions detection all along the
digestive tract and not limited to the colon only.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03278912 -
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
|
||
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05579392 -
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
|
N/A | |
Completed |
NCT03264690 -
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
|
||
Recruiting |
NCT02861053 -
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
|
N/A | |
Recruiting |
NCT02275676 -
Resting Energy Expenditure and Nutritional Status in IBD
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT02161640 -
Vascular Dysfunction in Paediatric IBD
|
N/A | |
Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT01933867 -
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
|
N/A | |
Completed |
NCT01852760 -
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
|
N/A | |
Completed |
NCT01676324 -
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01688557 -
Trial on Innovative Technologies in Colonoscopy
|
N/A | |
Completed |
NCT01692743 -
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
|
Phase 3 | |
Completed |
NCT01666535 -
Infliximab IBD Influenza Vaccine Study
|
N/A | |
Completed |
NCT01557387 -
Real-time Diagnosis of Pseudopolyps During Colonoscopy
|
||
Completed |
NCT01981616 -
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
|
Phase 1 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01221818 -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
|
Phase 1 |